{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T07:57:07Z","timestamp":1789286227499,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.hpb.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T12:13:57Z","timestamp":1716293637000},"page":"1082-1085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program"],"prefix":"10.1016","volume":"26","author":[{"given":"Andrew","family":"Hendifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-2309","authenticated-orcid":false,"given":"Megan","family":"Hitchins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-139X","authenticated-orcid":false,"given":"Marie","family":"Lauzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0849-7018","authenticated-orcid":false,"given":"Kathryn E.","family":"Hatchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandie","family":"Heald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0818-6017","authenticated-orcid":false,"given":"Stephen","family":"Pandol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjaparavanda P.","family":"Naren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsen","family":"Osipov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2024.05.005_bib1","series-title":"Cancer facts & figures 2022","year":"2022"},{"key":"10.1016\/j.hpb.2024.05.005_bib2","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer","volume":"319","author":"Hu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.hpb.2024.05.005_bib3","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1002\/cncr.29664","article-title":"Identification of germline genetic mutations in patients with pancreatic cancer","volume":"121","author":"Salo-Mullen","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2024.05.005_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.48721","article-title":"Prevalence of germline sequence variations among patients with pancreatic cancer in China","volume":"5","author":"Yin","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hpb.2024.05.005_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in Oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.hpb.2024.05.005_bib6","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1200\/JCO.20.01364","article-title":"Metastatic pancreatic cancer: ASCO guideline update","volume":"38","author":"Sohal","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2024.05.005_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1172\/JCI639","article-title":"Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation","volume":"101","author":"Cuppens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hpb.2024.05.005_bib8","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1073\/pnas.0400182101","article-title":"A\u00a0variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing","volume":"101","author":"Hefferon","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hpb.2024.05.005_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0293-151","article-title":"Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA","volume":"3","author":"Chu","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.hpb.2024.05.005_bib10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/humu.24250","article-title":"Elucidating clinical phenotypic variability associated with the polyT tract and TG repeats in CFTR","volume":"42","author":"Nykamp","year":"2021","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hpb.2024.05.005_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/humu.22129","article-title":"CFTR mutation combinations producing frequent complex alleles with different clinical and functional outcomes","volume":"33","author":"El-Seedy","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.hpb.2024.05.005_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009100","article-title":"Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies","volume":"16","author":"Joynt","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.hpb.2024.05.005_bib13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1164\/rccm.202101-0090LE","article-title":"Elexacaftor\/tezacaftor\/ivacaftor improved clinical outcomes in a patient with N1303K-CFTR based on in\u00a0vitro experimental evidence","volume":"204","author":"Huang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hpb.2024.05.005_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ebiom.2019.09.032","article-title":"Natural history of SPINK1 germline mutation related-pancreatitis","volume":"48","author":"Muller","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.hpb.2024.05.005_bib15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/gut.2005.074534","article-title":"Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma","volume":"54","author":"McWilliams","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2024.05.005_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group","volume":"332","author":"Neglia","year":"1995","journal-title":"N Engl J Med"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24017210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X24017210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T01:37:43Z","timestamp":1754012263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X24017210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1365182X24017210"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2024.05.005","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High frequency of germline variants in CFTR identified in PDAC patients enrolled in an expanded panel multi-gene panel testing program","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}